Use of bladder dose points for assessment of the spatial dose distribution in the posterior bladder wall in cervical cancer brachytherapy and the impact of applicator position
PURPOSE: To validate the feasibility and use of dose points to characterize the bladder wall dose distribution and investigate potential impact of the applicator position in cervical cancer brachytherapy. METHODS AND MATERIALS: One hundred twenty-eight optimized MRI plans were evaluated. The International Commission of Radiation Units and Measurements (ICRU-38) point doses (Brow), surrogate for bladder base doses, were compared with D-2cc. Vaginal source to superior-anterior border of the symphysis distances were measured and compared within two groups, namely Group 1-B-ICRU/D-2cc >= 1 and Group 2-B-ICRU/D-2cc <1. Additionally, points at 1.5 and 2 cm cranial to the B-ICRU, parallel to the tandem and the body axis were analyzed. RESULTS: Thirty-seven percent of the patients had the ratio B-ICRU/D-2cc of 1 or higher, with the 2cc subvolume at the bladder base (Group 1). In 63%, B-ICRU/D-2cc, ratio was lower than 1 and the 2cc, cranial to the bladder base (Group 2). Median vaginal source-to-superior anterior border of the symphysis line distance was -2 cm (range, -3.7 to + 1.2 cm) in Group 1 and +1.8 cm (range, -2 to +4.8 cm) in Group 2 (+ cranial/- caudal direction). There was a high correlation between vaginal sources near the symphysis and the 2cc subvolume at the bladder base. The additional points provided no added value. CONCLUSIONS: Location of the 2cc subvolume varies in cervical cancer brachytherapy. Maximum doses are at the bladder base if vaginal sources are also in the vicinity of the bladder base indicated by B-ICRU/D-2cc ratio of 1 or higher. Such variation should be considered in dose-effect analyses and intercomparisons, as the same D-2cc at different bladder locations may correlate with different morbidity profiles and severity Reporting D-2cc and B-ICRU doses together therefore remains essential. (C) 2015 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.
机构:
Int Med Ctr Banja Luka, Ctr Radiotherapy, Banja Luka 78000, Bosnia & HercegInt Med Ctr Banja Luka, Ctr Radiotherapy, Banja Luka 78000, Bosnia & Herceg
Marosevic, Goran
Ljuca, Dzenita
论文数: 0引用数: 0
h-index: 0
机构:
Univ Clin Ctr Tuzla, Gynaecol & Obstet Clin, Tuzla, Bosnia & HercegInt Med Ctr Banja Luka, Ctr Radiotherapy, Banja Luka 78000, Bosnia & Herceg
Ljuca, Dzenita
Osmic, Hasan
论文数: 0引用数: 0
h-index: 0
机构:
Univ Clin Ctr Tuzla, Dept Radiotherapy, Tuzla, Bosnia & HercegInt Med Ctr Banja Luka, Ctr Radiotherapy, Banja Luka 78000, Bosnia & Herceg
Osmic, Hasan
Fazlic, Semir
论文数: 0引用数: 0
h-index: 0
机构:
Univ Clin Ctr Tuzla, Dept Radiotherapy, Tuzla, Bosnia & HercegInt Med Ctr Banja Luka, Ctr Radiotherapy, Banja Luka 78000, Bosnia & Herceg
Fazlic, Semir
Arsovski, Oliver
论文数: 0引用数: 0
h-index: 0
机构:
Int Med Ctr Banja Luka, Ctr Radiotherapy, Banja Luka 78000, Bosnia & HercegInt Med Ctr Banja Luka, Ctr Radiotherapy, Banja Luka 78000, Bosnia & Herceg
Arsovski, Oliver
Mileusnic, Dusan
论文数: 0引用数: 0
h-index: 0
机构:
Int Med Ctr Banja Luka, Ctr Radiotherapy, Banja Luka 78000, Bosnia & HercegInt Med Ctr Banja Luka, Ctr Radiotherapy, Banja Luka 78000, Bosnia & Herceg
机构:
Gynecology Department of Tumor Center ,the First Affiliated Hospital , Medical School of Xi'an Jiao-tong University
2. Gynecology Department of Tumor Center ,the First Affiliated Hospital , Medical SGynecology Department of Tumor Center ,the First Affiliated Hospital , Medical School of Xi'an Jiao-tong University
2. Gynecology Department of Tumor Center ,the First Affiliated Hospital , Medical S
刘孜
高莹
论文数: 0引用数: 0
h-index: 0
机构:
Gynecology Department of Tumor Center ,the First Affiliated Hospital , Medical School of Xi'an Jiao-tong University
2. Gynecology Department of Tumor Center ,the First Affiliated Hospital , Medical SGynecology Department of Tumor Center ,the First Affiliated Hospital , Medical School of Xi'an Jiao-tong University
2. Gynecology Department of Tumor Center ,the First Affiliated Hospital , Medical S
高莹
罗伟
论文数: 0引用数: 0
h-index: 0
机构:
Gynecology Department of Tumor Center ,the First Affiliated Hospital , Medical School of Xi'an Jiao-tong University
2. Gynecology Department of Tumor Center ,the First Affiliated Hospital , Medical SGynecology Department of Tumor Center ,the First Affiliated Hospital , Medical School of Xi'an Jiao-tong University
2. Gynecology Department of Tumor Center ,the First Affiliated Hospital , Medical S
罗伟
王国庆
论文数: 0引用数: 0
h-index: 0
机构:
Gynecology Department of Tumor Center ,the First Affiliated Hospital , Medical School of Xi'an Jiao-tong University
2. Gynecology Department of Tumor Center ,the First Affiliated Hospital , Medical SGynecology Department of Tumor Center ,the First Affiliated Hospital , Medical School of Xi'an Jiao-tong University
2. Gynecology Department of Tumor Center ,the First Affiliated Hospital , Medical S
王国庆
王蕊花
论文数: 0引用数: 0
h-index: 0
机构:
Gynecology Department of Tumor Center ,the First Affiliated Hospital , Medical School of Xi'an Jiao-tong University
2. Gynecology Department of Tumor Center ,the First Affiliated Hospital , Medical SGynecology Department of Tumor Center ,the First Affiliated Hospital , Medical School of Xi'an Jiao-tong University
2. Gynecology Department of Tumor Center ,the First Affiliated Hospital , Medical S
王蕊花
郑伟
论文数: 0引用数: 0
h-index: 0
机构:
Gynecology Department of Tumor Center ,the First Affiliated Hospital , Medical School of Xi'an Jiao-tong University
2. Gynecology Department of Tumor Center ,the First Affiliated Hospital , Medical SGynecology Department of Tumor Center ,the First Affiliated Hospital , Medical School of Xi'an Jiao-tong University
2. Gynecology Department of Tumor Center ,the First Affiliated Hospital , Medical S
郑伟
刘锐
论文数: 0引用数: 0
h-index: 0
机构:Gynecology Department of Tumor Center ,the First Affiliated Hospital , Medical School of Xi'an Jiao-tong University
2. Gynecology Department of Tumor Center ,the First Affiliated Hospital , Medical S